A Retrospective Observational Study of Ustekinumab Among Bio-naive Participants With Crohn's Disease in China
Clinical trial NCT06082986 · COMPLETED
Trial details
- NCT number
- NCT06082986
- Sponsor
- Xian-Janssen Pharmaceutical Ltd.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-10-09
- Primary completion
- 2024-06-05
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.